Title restor3d receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System
restor3d, a leader in 3D-printed, personalized orthopedic implant care, has received FDA 510(k) clearance for the iTotal Identity™ CR 3DP Porous Total Knee Replacement System. This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in Q3 of 2025.
Choose Your Motion with restor3d: Introducing the Latest Personalized Solution in the Kinos Total Ankle System, Kinos Range
restor3d, the medical technology leader in 3D printed, personalized orthopedic implants across the entire human body, announced the launch of its latest patient-centric innovation, the addition of the Kinos Range articulating surface to the Kinos Total Ankle System. This new offering of vitamin E, highly crosslinked polyethylene and 3D printed cobalt chrome implants represents a significant advancement in ankle arthroplasty, allowing surgeons to assess soft tissue integrity intraoperatively and tailor the resulting articulation to meet each patient’s specific needs. The full system will be on show at the upcoming American Orthopaedic Foot & Ankle Society (AOFAS) and Orthopaedic Summit (OSET) Annual Meetings 2024.
restor3d Expands into Robotics and Navigation with Strategic Leadership Hires
restor3d, the medical technology leader in 3D printed, personalized orthopedic implants, announced its strategic expansion into the field of robotics and navigation through the appointment of seasoned leaders, Larry Hazbun and Kirstin Widding.
restor3d Announces Successful Closing of $70 Million Financing
restor3d, the leader in 3D printed, personalized orthopedic implants, announced today the successful closing of a $55 million Series A funding round led by private investors including Summers Value Partners and existing investors plus an additional $15 million in debt financing led by Trinity Capital. This significant investment will accelerate the company’s growth and innovation in several key areas:
Scaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis Acquisition
On September 5, 2023, restor3d, Inc. finalized its previously announced acquisition of Conformis, Inc. With this merger complete, there is tremendous opportunity to deliver clinically differentiated and cost-effective solutions across the orthopaedic landscape.
